amd treatment using aflibercept aav2 variant

摘要

The present invention relates to pharmaceutical compositions and their methods for treating age-related macular degeneration (amd) in an individual by intravitreal administration of a pharmaceutical composition adapted for gene therapy, comprising a vector having a sequence of nucleic acid encoding aflibercept.